A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B
Public ClinicalTrials.gov record NCT02418793. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2a, Open-Label, Multicenter, Dose Escalation Study to Assess the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) Profile of a Long Acting Recombinant FVIIa (MOD-5014) in Adult Men With Hemophilia A or B
Study identification
- NCT ID
- NCT02418793
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- OPKO Health, Inc.
- Industry
- Enrollment
- 27 participants
Conditions and interventions
Conditions
Interventions
- MOD-5014 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2015
- Primary completion
- Aug 31, 2018
- Completion
- Aug 31, 2018
- Last update posted
- May 19, 2021
2015 – 2018
United States locations
- U.S. sites
- 11
- U.S. states
- 5
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope | Duarte | California | — | — |
| Children's Hospital Los Angeles | Los Angeles | California | 90027 | — |
| Orthopaedic Hemophilia Treatment Center | Los Angeles | California | — | — |
| University of California Davis Medical Center | Sacramento | California | — | — |
| Rush University Medical Center | Chicago | Illinois | — | — |
| Bleeding & Clotting Disorders Institute | Peoria | Illinois | — | — |
| Indiana Hemophilia & Thrombosis Center | Indianapolis | Indiana | — | — |
| Penn State Milton S. Hershey Medical Center | Hershey | Pennsylvania | — | — |
| UPMC Presbyterian Shadyside | Pittsburgh | Pennsylvania | — | — |
| UT Southwestern Medical Center | Dallas | Texas | — | — |
| The Gulf States Hemophilia and Thrombophilia Center | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02418793, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 19, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02418793 live on ClinicalTrials.gov.